Glipizide
Product Images NDC 60760-329

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 60760-329). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glip (Glipizide 60760 329 30)

Glipizide Extended-Release Tablets 5 mg carton label showing a quantity of 30 tablets. The label includes the NDC 60760-329-30 and Rx only designation. It is manufactured by Aurobindo Pharma USA, Inc., made in India, and packaged by St. Mary's Medical Park Pharmacy in Oro Valley, AZ. Instructions include 'Use as directed' and storage at controlled room temperature 15°-30°C (59°-86°F).*

FDA Label Image

Chemical Structure (Glipizide Str)

Chemical structure of Glipizide, illustrating the molecular components and bonds characteristic of this active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.